Rheumatic heart disease [RHD] is the most prevalent cause of valvular heart disease in the
world, outstripping degenerative aortic stenosis numbers fourfold. Despite this, global …

Valvular heart disease (VHD) has become a burden and a growing public health problem in
humans, causing significant morbidity and mortality worldwide. An increasing number of …

Due to the increasing aging population and the advancements in transcatheter aortic valve
replacement (TAVR), the use of bioprosthetic heart valves (BHVs) in patients diagnosed with …

The effect of monomeric glutaraldehyde fixation and amino acid detoxification on
biocompatibility and tissue-guided regenerative potential of decellularized bovine …

Urinary tract infections and urinary encrustation impede the long-term clinical performance
of urological implants and medical devices. Together, biofilm formation and encrustation …

Right ventricular outflow tract (RVOT) reconstruction is a common surgical method to treat
congenital cardiac lesions, and bovine jugular vein conduit (BJVC) has become a prevalent …

Background Bioprosthetic heart valves (BHVs) are less thrombogenic than mechanical
prostheses; however, BHV thrombosis has been proposed as a risk factor for premature …

Valvular heart disease (VHD), clinically manifested as stenosis and regurgitation of native
heart valve, is one of the most prevalent cardiovascular diseases with high mortality. Heart …

Congenital heart disease (CHD) affects around 1.35 million neonates worldwide per annum,
and surgical repair is necessary in approximately 25% of cases. Xenografts, usually of …

The number of patients with valvular heart disease is increasing yearly, and valve
replacement is the most effective treatment, during which bioprosthetic heart valves (BHVs) …